Bid feeds debate on cost of devices
Boston Scientific, Guidant part of the medical tech boom that has driven healthcare prices higher
At the center of the proposed merger of Boston Scientific Corp. and Guidant Corp. lie two highly profitable heart-repair devices that have boosted their makers' bottom lines, but are also part of a technology boom that has sharply increased the cost of healthcare in the United States.Guidant deal could close by early next year. E8 (Full article: 887 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
